De-Escalating Treatment in Metastatic HER2+ Breast Cancer: Is it Safe?

Researchers tested omitting chemotherapy from a treatment regimen involving dual blockade with pertuzumab and trastuzumab in patients with metastatic HER2+ breast cancer.

Source: CancerNetwork - May 1, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news